Best Primary Care Practices for Hepatitis B Infection: Focus on Therapeutic Strategy Planning and Treatment Counseling
CMEO Chart ReviewPremiere Date: Thursday, December 20, 2012
This activity offers CE credit for:
- Physicians (CME)
- Nurses (CNE)
- Pharmacists (ACPE)
- Family Physicians (AAFP)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date: Wednesday, January 22, 2014
Larry Culpepper, MD, MPH (Moderator)
Professor of Family Medicine
Boston University School of Medicine
Staff Physician, Family Medicine
Boston Medical Center
Tram T. Tran, MD
Medical Director, Liver Transplantation
Medical Director of Hepatology
Cedars-Sinai Medical Center
Associate Professor of Medicine
The David Geffen School of Medicine at UCLA
Los Angeles, CA
According to the report by the Institute of Medicine entitled Hepatitis and Liver Cancer: Information for Health Care Providers, chronic infection with hepatitis B virus constitutes a public health problem—one that primary care clinicians can play a critical role in addressing. Specifically, the report calls for frontline clinicians to increase screening of at-risk adults, provide better patient education about HBV serologic results, and strengthen efforts toward patient access to treatment and monitoring services.
This CME Outfitters Chart Review webcast features national experts as your guides on a patient case expedition that will cover the terrain of current national guidelines from AASLD, emerging data, and expert experience. This Chart Review focuses on primary care-based treatment and counseling before specialist referral. A companion Chart Review covers HBV infection screening and diagnosis. Learners are encouraged to participate in that activity, although it is not a prerequisite for participation in this one. Both Chart Reviews follow a Live and On Demand activity, the flagship experience in the CME Outfitters vWorld™ virtual learning environment.
- Colvin HM, Mitchell AE, eds.; Institute of Medicine Committee on the Prevention and Control of Viral Hepatitis Infections, Board on Population Health and Public Health Practice. Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. Washington, DC: National Academies Press; 2011. http://books.nap.edu/openbook.php?record_id=12793. Accessed October 15, 2012.
- Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50(3):661-662. PMID: 19714720.
Additional Education on Hepatitis B: Join the faculty for an additional opportunity to continue the interaction and to discuss clinical case challenges you see in your practice.
- Best Primary Care Practices for Hepatitis B Infection: Focus on Screening and Diagnosis
with Dr. Kowdley and Dr. Wang.
For information and to participate Click Here
To educate primary care clinicians, in accordance with guidelines, on using effective management and counseling strategies for adults who have or who are at risk of developing chronic viral hepatitis due to hepatitis B virus infection.
At the end of this CE activity, participants should be able to:
- Devise plans or refer patients infected with hepatitis B virus for ongoing monitoring, follow-up, and determination of treatment candidacy.
- Counsel patients infected with hepatitis B virus about therapeutic goals and available treatments before referring patients to hepatology specialists.
The following learning objectives pertain only to those requesting CNE credit:
- Identify resources that can be used to assist in making local effective referrals of patients infected with hepatitis B virus to specialist care.
- Identify the therapeutic goals of hepatitis treatment according to American Association for the Study of Liver Diseases (AASLD) guidelines.
Supported by educational grants from Bristol-Myers Squibb and Gilead Sciences, Inc.
Physicians, physician assistants, nurses, nurse practitioners, pharmacists, and other health care professionals whose scope of practice involves providing primary care for adults who have or who are at risk of developing chronic viral hepatitis.
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAFP Credit (Family Physicians):
This enduring material activity, Best Primary Care Practices for Hepatitis B Infections: Focus on Therapeutic Strategy Planning and Treatment Counseling, has been reviewed and is acceptable for up to 1 Prescribed credit(s) by the American Academy of Family Physicians. AAFP certification begins December 20, 2012. Term of approval is for one year from this date with the option of yearly renewal. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.0 contact hour.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs)
Universal Activity Number: 0376-0000-12-021-H01-P (recorded programs)
Activity Type: knowledge-based
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Culpepper has disclosed that he serves as a consultant to AstraZeneca Pharmaceuticals LP; Forest Laboratories Inc.; Janssen Pharmaceuticals, Inc.; Lunbeck; Merck & Co., Inc; Pfizer Inc; and Takeda Pharmaceuticals USA, Inc. Dr. Culpepper serves on the speakers bureau for Merck & Co., Inc.
Dr. Tran has disclosed that she received grants/research support from Bristol-Myers Squibb Company and Gilead Sciences, Inc. She serves as a consultant to Bristol-Myers Squibb Company; and Gilead Sciences, Inc.
Ruth Cody, BSN, RN-BC (content/peer reviewer) has no disclosures to report.
Nancy Jennings, MSN, MBA, MHA, RNC (content/peer reviewer) has no disclosures to report.
Monique Johnson, MD, CCMEP (planning committee) has no disclosures to report.
Joy Bartnett Leffler, MLA, NASW, CSE (planning committee) has no disclosures to report.
Sandra Haas Binford, MAEd (planning committee) has no disclosures to report.
Sharon Tordoff, CCMEP (planning committee) has no disclosures to report.
Unlabeled Use Disclosure
Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
CME Outfitters, LLC, the faculty, Bristol-Myers Squibb, and Gilead Sciences, Inc. do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
This document was last modified on: